InvestorsHub Logo
Followers 15
Posts 1324
Boards Moderated 0
Alias Born 07/23/2013

Re: None

Thursday, 12/26/2013 12:52:00 PM

Thursday, December 26, 2013 12:52:00 PM

Post# of 146240
Doing some 10-K reading on NNVC before making an additional investment. I see the technology is licensed from Theracour in perpetuity. My question is, does anyone know for sure the terms of these licenses? Seeking $ amounts, dates of importance, restrictions to NNVC shareholders. Anyone have the info?

Here is the quote from 10-K:

The Company plans to develop several different nanoviricide drugs against a number of human viral diseases. The Company initially obtained an exclusive license in perpetuity to develop drugs based on technologies originally created by TheraCour Pharma, Inc., (TheraCour) against the following human viral diseases: H5N1 (Avian Flu), Human Influenza, Human Immunodeficiency Virus (HIV/AIDS), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Herpes Simplex Virus (HSV), and Rabies, including all known strains of these viruses. The Company has entered into an Additional License Agreement with TheraCour granting the Company the exclusive licenses in perpetuity for technologies developed by TheraCour for the additional virus types for Dengue viruses, Japanese Encephalitis virus, West Nile Virus, Viruses causing viral Conjunctivitis (a disease of the eye) and Ocular Herpes, and Ebola/Marburg viruses.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News